Capital Advisors Inc’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-80,000
Closed -$46.9K 362
2025
Q3
$46.9K Buy
80,000
+60,000
+300% +$468K ﹤0.01% 336
2025
Q2
$62.7K Buy
+20,000
New +$145K ﹤0.01% 319
2021
Q4
Sell
-77,166
Closed -$9.79M 255
2021
Q3
$9.79M Buy
77,166
+3,485
+5% +$507K 0.29% 91
2021
Q2
$12.3M Buy
73,681
+7,855
+12% +$1.27M 0.37% 90
2021
Q1
$12M Buy
65,826
+5,783
+10% +$1.34M 0.39% 85
2020
Q4
$12M Buy
60,043
+5,569
+10% +$1.13M 0.43% 81
2020
Q3
$11.9M Buy
54,474
+1,638
+3% +$347K 0.48% 74
2020
Q2
$11.2M Sell
52,836
-23,992
-31% -$4.2M 0.47% 76
2020
Q1
$11.9M Buy
+76,828
New +$8.94M 0.65% 57

Other funds holding TDOC

Capital Advisors Inc's TDOC Position: Q4 2025 in Review

Capital Advisors Inc sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 80,000 shares — an estimated $46.9K sold.

Capital Advisors Inc first reported a position in TDOC in Q1 2020 and held it in 9 quarters. The position peaked at $12.3M in Q2 2021. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Capital Advisors Inc reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Capital Advisors Inc sold 80,000 Teladoc Health shares in Q4 2025, an estimated $46.9K.
  • Capital Advisors Inc first reported a position in Teladoc Health in Q1 2020 and held it in 9 quarters.
  • Capital Advisors Inc's Teladoc Health position peaked at $12.3M in Q2 2021.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Capital Advisors Inc's 13F filing for Q4 2025, filed 15 Jan 2026.